Withdrawn plans to expand Proud study

Given that the PROUD pilot study has answered the important question of how much protection daily Truvada can offer when provided in sexual health clinics in the UK, there is no need for the planned larger clinical trial. As such, we have withdrawn our funding application to reopen the PROUD study for new recruitment.

In addition to daily Truvada, there is a range of other PrEP options in various stages of research. We are in the process of talking to our partner organisations in order to identify which PrEP research questions we should address next in the UK.

Contact Us

MRC Clinical Trials Unit at UCL

90 High Holborn

Email: mrcctu.trial-proud@ucl.ac.uk